Speaker(s): 

John Samies, DO Fellow, Geisinger, GCMC - has nothing to disclose.

Duane E. Deivert, DO, Geisinger GWV - has the following disclosures: BioNTech (Stockholder), Exact Sciences (Stockholder), Moderna (Stockholder), Eli Lilly (Stockholder).

Moderator: 

Shri Jai Kirshan Ravi, MD, Geisinger, GCMC - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Acquire about trial showing efficacy of Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP
• Acquire for blood test for detection of colorectal cancer

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Shri Jai Kirsha Ravi, MD, Pati Pawlik, RN and Jillian Evarts, PA-C have no identified disclosures. 

Duane Deivert, DO, has the following disclosures: BioNTech (Stockholder), Exact Sciences (Stockholder), Moderna (Stockholder), Eli Lilly (Stockholder). 

Abhinav Goyal, MD has the following disclosures: Pfizer (Stockholder), Moderna (Stockholder). 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session

None.